On February 24, 2022 Primmune Therapeutics, a biotech company harnessing the power of the innate immune system to treat cancers and viral diseases, reported that Charles McDermott, President and Chief Executive Officer of Primmune, will present at the 12th Annual Global Life Science Partnering Conference, presented by Biocom California, which will be held Feb. 22 to 24 in San Diego (Press release, Primmune Therapeutics, FEB 24, 2022, View Source [SID1234608982]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

12th Annual Global Life Science Partnering Conference

Date: Thursday, February 24
Time: 11:15 a.m. PT

More information about the conference can be found here.